HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
Resource Type
Article
Authors
Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi ; Radford, John ; Maddocks, Kami ; Pinto, Antonio ; Collins, Graham P. ; Bachanova, Veronika ; Bartlett, Nancy ; Bence-Bruckler, Isabelle ; Hamadani, Mehdi ; Kline, Justin ; Mayer, Jiri ; Savage, Kerry J. ; Advani, Ranjana ; Calmi, Paolo ; Casasnovas, René-Olivier ; Feldman, Tatyana ; Hess, Brian ; Bastos-Oreiro, Mariana ; Iyengar, Sunil ; Eisen, Sandy ; Negievich, Yanina ; Wang, Luqiang ; Wuerthner, Jens ; Herrera, Alex F.
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S347-S347
Subject
Language
ISSN
2152-2650